Terms: = Thyroid cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
143 results:
1. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape.
Zhu W; Rao J; Zhang LH; Xue KM; Li L; Li JJ; Chen QZ; Fu R
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604814
[TBL] [Abstract] [Full Text] [Related]
2. Causal relationship between inflammatory cytokines and autoimmune thyroid disease: a bidirectional two-sample Mendelian randomization analysis.
Yao Z; Guo F; Tan Y; Zhang Y; Geng Y; Yang G; Wang S
Front Immunol; 2024; 15():1334772. PubMed ID: 38571956
[TBL] [Abstract] [Full Text] [Related]
3. SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
Wu Y; Chen W; Miao H; Xu T
BMC Cancer; 2024 Feb; 24(1):210. PubMed ID: 38360598
[TBL] [Abstract] [Full Text] [Related]
4. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis.
Gao S; Wang Y; Xu Y; Liu L; Liu S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167011. PubMed ID: 38176460
[TBL] [Abstract] [Full Text] [Related]
5. Regulatory and Interacting Partners of PDLIM7 in thyroid cancer.
Rood K; Yamauchi CR; Sharma U; Laxa RT; Robins C; Lanza G; Sánchez-Ruiz K; Khan A; Kim HS; Shields A; Kennedy K; Mirshahidi S; Perez MC; Firek A; Munir I; Simental AA; Khan S
Curr Oncol; 2023 Dec; 30(12):10450-10462. PubMed ID: 38132395
[TBL] [Abstract] [Full Text] [Related]
6. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
[TBL] [Abstract] [Full Text] [Related]
7. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
Qiao L; Dong C; Jia W; Ma B
Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
[TBL] [Abstract] [Full Text] [Related]
8. Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer.
Wang J; Niu Y; Yang M; Shu L; Wang H; Wu X; He Y; Chen P; Zhong G; Tang Z; Zhang S; Guo Q; Wang Y; Yu L; Gou D
Epigenetics Chromatin; 2023 Sep; 16(1):33. PubMed ID: 37740218
[TBL] [Abstract] [Full Text] [Related]
9. A tumor-suppressing role of TSPYL2 in thyroid cancer: Through interacting with SIRT1 and repressing SIRT1/AKT pathway.
Zhang X; Wu X; Yao W; Wang YH
Exp Cell Res; 2023 Nov; 432(1):113777. PubMed ID: 37696385
[TBL] [Abstract] [Full Text] [Related]
10. SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway.
Ma J; Huang X; Xu J; Li Z; Lai J; Shen Y; Zhao J; Sun X; Ma L
Mol Med; 2023 Sep; 29(1):121. PubMed ID: 37684566
[TBL] [Abstract] [Full Text] [Related]
11. Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment.
Zhang L; Qiu L; Xu S; Cheng X; Wu J; Wang Y; Gao W; Bao J; Yu H
Toxicol In Vitro; 2023 Dec; 93():105669. PubMed ID: 37634662
[TBL] [Abstract] [Full Text] [Related]
12. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract] [Full Text] [Related]
13. [Establishment and validation of a nomogram model for evaluating the metastasis of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma].
Wang ZY; Chang QG; Guo HH; Du X; Liu YH; Yin DT
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2175-2182. PubMed ID: 37482730
[No Abstract] [Full Text] [Related]
14. Analyzing County-level Social Vulnerabilities of Head and Neck Melanomas in the United States.
McCampbell L; Fei-Zhang DJ; Chelius D; Rastatter J; Sheyn A
Laryngoscope; 2024 Jan; 134(1):185-190. PubMed ID: 37341511
[TBL] [Abstract] [Full Text] [Related]
15. Oridonin inhibits the occurrence and development of colorectal cancer by reversing the Warburg effect via reducing PKM2 dimer formation and preventing its entry into the nucleus.
Chen F; Liao J; Wu P; Cheng L; Ma Y; Zhang L; Leng X; Zhu X; Liu Z; Xie F
Eur J Pharmacol; 2023 Sep; 954():175856. PubMed ID: 37321470
[TBL] [Abstract] [Full Text] [Related]
16. Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis.
Nam M; Yang W; Kim HS; Park J; Park G; Kim S; Song S; Ock CY; Wang VG; Chuang JH; Chae YK
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37279258
[TBL] [Abstract] [Full Text] [Related]
17. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.
Feng Z; Ke S; Wang C; Lu S; Xu Y; Yu H; Li Z; Yin B; Li X; Hua Y; Qian B; Bai M; Fu Y; Zhang Y; Wu Y; Ma Y
Oncogene; 2023 Jun; 42(24):2017-2030. PubMed ID: 37142680
[TBL] [Abstract] [Full Text] [Related]
18. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.
Zheng W; Wang X; Yu Y; Ji C; Fang L
Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128
[TBL] [Abstract] [Full Text] [Related]
19. PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis.
Liu A; Yu C; Qiu C; Wu Q; Huang C; Li X; She X; Wan K; Liu L; Li M; Wang Z; Chen Y; Hu F; Song D; Li K; Zhao C; Deng H; Sun X; Xu F; Lai S; Luo X; Hu J; Wang G
Oncogene; 2023 May; 42(19):1572-1584. PubMed ID: 36991117
[TBL] [Abstract] [Full Text] [Related]
20. ACAT1-mediated METTL3 acetylation inhibits cell migration and invasion in triple negative breast cancer.
Zhang G; Huang R; Zhao H; Xia Y; Huang H; Qian M; Fu Y; Cui Y
Genes Immun; 2023 Apr; 24(2):99-107. PubMed ID: 36890220
[TBL] [Abstract] [Full Text] [Related]
[Next]
